近岸蛋白
(688137)
| 流通市值：11.92亿 | | | 总市值：25.60亿 |
| 流通股本：3267.54万 | | | 总股本：7017.54万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 92,079,068.48 | 59,655,247.04 | 26,087,054.66 | 153,191,370.39 |
| 营业收入 | 92,079,068.48 | 59,655,247.04 | 26,087,054.66 | 153,191,370.39 |
| 二、营业总成本 | 115,556,413.23 | 76,651,133.2 | 35,231,255.14 | 143,259,290.29 |
| 营业成本 | 32,652,717.32 | 21,880,716.91 | 8,275,316.47 | 37,273,866.81 |
| 税金及附加 | 1,212,448.88 | 799,430.34 | 382,921.78 | 849,048.14 |
| 销售费用 | 34,818,725.83 | 23,228,529.46 | 11,402,508.31 | 43,578,624.86 |
| 管理费用 | 37,305,567.98 | 24,506,313.56 | 11,806,901.67 | 44,257,603.92 |
| 研发费用 | 33,757,447.63 | 22,415,456.03 | 11,000,774.78 | 44,788,915.39 |
| 财务费用 | -24,190,494.41 | -16,179,313.1 | -7,637,167.87 | -27,488,768.83 |
| 其中:利息费用 | 2,782,177.92 | 1,909,672.71 | 982,526.09 | 3,585,866.48 |
| 其中:利息收入 | 27,524,514.45 | 17,846,154.11 | 8,564,906.56 | 30,479,502.38 |
| 加:公允价值变动收益 | -1,804,926.16 | -1,804,926.16 | -1,804,926.16 | -1,748,049.19 |
| 加:投资收益 | 4,569,887.11 | 4,569,887.11 | 4,569,887.11 | 18,939,889.24 |
| 资产处置收益 | - | - | - | 145.97 |
| 资产减值损失(新) | -19,097,136.16 | -14,414,916.44 | -7,608,392.83 | -33,419,646.99 |
| 信用减值损失(新) | -3,525,505.81 | -2,970,046.26 | -28,696.43 | 1,142,584.27 |
| 其他收益 | 16,364,793.21 | 15,631,660.74 | 9,018,682.09 | 11,665,012.87 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -26,970,232.56 | -15,984,227.17 | -4,997,646.7 | 6,512,016.27 |
| 加:营业外收入 | 48,257.1 | 47,376.2 | 4,900 | 20.59 |
| 减:营业外支出 | 676,107.9 | 541,718.7 | 509,653.29 | 289,815.36 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -27,598,083.36 | -16,478,569.67 | -5,502,399.99 | 6,222,221.5 |
| 减:所得税费用 | -9,339,548.27 | -7,572,775.9 | -2,871,925.31 | -6,621,351.01 |
| 六、净利润 | -18,258,535.09 | -8,905,793.77 | -2,630,474.68 | 12,843,572.51 |
| 持续经营净利润 | -18,258,535.09 | -8,905,793.77 | -2,630,474.68 | 12,843,572.51 |
| 归属于母公司股东的净利润 | -18,258,535.09 | -8,905,793.77 | -2,630,474.68 | 12,843,572.51 |
| (一)基本每股收益 | -0.26 | -0.13 | -0.04 | 0.18 |
| (二)稀释每股收益 | -0.26 | -0.13 | -0.04 | 0.18 |
| 八、其他综合收益 | 6,228.41 | -2,068.23 | -17,183.78 | -5,543.93 |
| 归属于母公司股东的其他综合收益 | 6,228.41 | -2,068.23 | -17,183.78 | -5,543.93 |
| 九、综合收益总额 | -18,252,306.68 | -8,907,862 | -2,647,658.46 | 12,838,028.58 |
| 归属于母公司股东的综合收益总额 | -18,252,306.68 | -8,907,862 | -2,647,658.46 | 12,838,028.58 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |